Literature DB >> 34921412

An update on current treatment strategies for laryngopharyngeal reflux symptoms.

Amanda J Krause1, Erin H Walsh2, Philip A Weissbrod2, Tiffany H Taft3, Rena Yadlapati1.   

Abstract

Laryngopharyngeal reflux (LPR) is a syndrome caused by reflux of gastric contents into the pharynx or larynx, which leads to symptoms of throat clearing, hoarseness, pain, globus sensation, cough, excess mucus production in the throat, and dysphonia. LPR is a challenging condition, as there is currently no gold standard for diagnosis or treatment, and thus this presents a burden to the healthcare system. Strategies for treatment of LPR are numerous. Medical therapies include proton pump inhibitors, which are first line, H2 receptor antagonists, alginates, and baclofen. Other noninvasive treatment options include lifestyle therapy and the external upper esophageal sphincter compression device. Endoscopic and surgical options include antireflux surgery, magnetic sphincter augmentation, and transoral incisionless fundoplication. Functional laryngeal disorders and laryngeal hypersensitivity can present as LPR symptoms with or without gastroesophageal reflux disease. Though there are minimal studies in this area, neuromodulators and behavioral interventions are potential treatment options. Given the complexity of these patients and numerous available treatment options, we propose a treatment algorithm to help clinicians diagnose and triage patients into an appropriate therapy.
© 2021 New York Academy of Sciences.

Entities:  

Keywords:  extraesophageal reflux; gastroesophageal reflux; laryngopharyngeal reflux; treatment

Mesh:

Substances:

Year:  2021        PMID: 34921412      PMCID: PMC9012673          DOI: 10.1111/nyas.14728

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   6.499


  73 in total

1.  Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders.

Authors:  J A Koufman; M R Amin; M Panetti
Journal:  Otolaryngol Head Neck Surg       Date:  2000-10       Impact factor: 3.497

2.  Hypnotherapy for Esophageal Disorders.

Authors:  Megan E Riehl; Laurie Keefer
Journal:  Am J Clin Hypn       Date:  2015-07

3.  Role of a health psychologist in the management of functional esophageal complaints.

Authors:  M E Riehl; S Kinsinger; P J Kahrilas; J E Pandolfino; L Keefer
Journal:  Dis Esophagus       Date:  2014-04-03       Impact factor: 3.429

4.  Acid-induced esophagobronchial-cardiac reflexes in humans.

Authors:  R A Wright; S A Miller; B F Corsello
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682

5.  Laryngopharyngeal Reflux and Functional Laryngeal Disorder: Perspective and Common Practice of the General Gastroenterologist.

Authors:  Dhyanesh A Patel; Michael Blanco; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-09

6.  Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux - a prospective comparative study.

Authors:  M Sereg-Bahar; A Jerin; R Jansa; B Stabuc; I Hocevar-Boltezar
Journal:  Clin Otolaryngol       Date:  2015-06       Impact factor: 2.597

7.  Outcomes of antireflux therapy for the treatment of chronic laryngitis.

Authors:  D G Hanson; P L Kamel; P J Kahrilas
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-07       Impact factor: 1.547

8.  The impact of laryngopharyngeal reflux on patient-reported quality of life.

Authors:  Ricardo L Carrau; Aliaa Khidr; Joseph A Crawley; Eric M Hillson; Judith K Davis; Chris L Pashos
Journal:  Laryngoscope       Date:  2004-04       Impact factor: 3.325

9.  Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.

Authors:  I Mainie; R Tutuian; S Shay; M Vela; X Zhang; D Sifrim; D O Castell
Journal:  Gut       Date:  2006-03-23       Impact factor: 23.059

10.  Treating laryngopharyngeal reflux: Evaluation of an anti-reflux program with comparison to medications.

Authors:  Jin Yang; Salem Dehom; Stephanie Sanders; Thomas Murry; Priya Krishna; Brianna K Crawley
Journal:  Am J Otolaryngol       Date:  2017-10-31       Impact factor: 1.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.